1. The p38 mitogen-activated protein kinase pathway—A potential target for intervention in infarction, hypertrophy, and heart failure
- Author
-
Marber, Michael S., Rose, Beth, and Wang, Yibin
- Subjects
- *
MITOGEN-activated protein kinases , *HEART diseases , *THERAPEUTICS , *CARDIAC hypertrophy , *HEART failure treatment , *ENZYME inhibitors , *CLINICAL trials , *ENZYME activation - Abstract
Abstract: The p38 mitogen-activated protein kinases (p38s) are stress-activated Ser/Thr kinases. Their activation has been associated with various pathological stressors in the heart. Activated p38 is implicated in a wide spectrum of cardiac pathologies, including hypertrophy, myocardial infarction, as well as systolic and diastolic heart failure. In this review, the specific contribution of different isoforms of p38 kinases to cardiac diseases as well as TAB-1-mediated non-canonical activation pathway are discussed as a rationale for inhibiting p38 activity to treat cardiac hypertrophy, ischemic injury, and heart failure. Finally, a summary of current clinical trials targeting p38 kinases in cardiovascular diseases is provided to highlight the potential promise as well as existing challenges of this therapeutic approach. This article is part of a special issue entitled “Key Signaling Molecules in Hypertrophy and Heart Failure.” [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF